Clinical Trial

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, controlled study to assess the effect of Sidekick Health's digital program on self-efficacy and medication adherence in breast cancer patients prescribed adjuvant anti-hormonal treatment. Participants will be treated with the digital program in addition to standard of care (SoC), or SoC only.
Trial Details
NCT Number NCT06989450
Lead Sponsor Sidekick Health
Collaborators: Landspitali University Hospital, University of Iceland, Icelandic Research Center
Conditions Breast Cancer, Cancer
Enrollment 140 participants
Start Date 2025-05-31
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-25